Alexander Karpeisky

1.4k total citations
35 papers, 1.1k citations indexed

About

Alexander Karpeisky is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Alexander Karpeisky has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 9 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Alexander Karpeisky's work include RNA and protein synthesis mechanisms (19 papers), DNA and Nucleic Acid Chemistry (12 papers) and Advanced biosensing and bioanalysis techniques (10 papers). Alexander Karpeisky is often cited by papers focused on RNA and protein synthesis mechanisms (19 papers), DNA and Nucleic Acid Chemistry (12 papers) and Advanced biosensing and bioanalysis techniques (10 papers). Alexander Karpeisky collaborates with scholars based in United States, India and United Kingdom. Alexander Karpeisky's co-authors include Leonid Beigelman, Nassim Usman, Jasenka Matulić‐Adamić, Shawn Zinnen, Peter Haeberli, David Sweedler, Douglas H. Thamm, Carolyn Gonzalez, Lara Maloney and James A. McSwiggen and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Alexander Karpeisky

34 papers receiving 983 citations

Peers

Countries citing papers authored by Alexander Karpeisky

Since Specialization

Citations

This map shows the geographic impact of Alexander Karpeisky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Karpeisky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Karpeisky more than expected).

Fields of papers citing papers by Alexander Karpeisky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Karpeisky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Karpeisky. The network helps show where Alexander Karpeisky may publish in the future.

Co-authorship network of co-authors of Alexander Karpeisky

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Karpeisky. A scholar is included among the top collaborators of Alexander Karpeisky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Karpeisky. Alexander Karpeisky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel Approaches to Monitor Pharmacokinetics and Metabolism of Gemcitabine-Ibandronate Conjugate in Mice and Dogs 2025 ·Molecules ·Jost Klawitter, (unknown), Alexander Karpeisky, (unknown), Douglas H. Thamm, Touraj Shokati, Uwe Christians, Shawn Zinnen	0
2	Bisphosphonate conjugation for bone specific drug targeting 2018 ·Bone Reports ·(unknown), Alexander Karpeisky, Douglas H. Thamm, Shawn Zinnen	133
3	First-in-Human Phase I Study of MBC-11, a Novel Bone-Targeted Cytarabine-Etidronate Conjugate in Patients with Cancer-Induced Bone Disease 2018 ·The Oncologist ·Shawn Zinnen, Alexander Karpeisky, Daniel D. Von Hoff, (unknown), Alexander I. Alexandrov	15
4	Evaluation of a novel bone targeted aracytidine therapy in dogs with spontaneous osteosarcoma 2010 ·Bone ·Shawn Zinnen, (unknown), David M. Vail, Timothy M. Fan, Alexander Karpeisky	4
5	Scaleable and efficient synthesis of 2′-deoxy-2′-N-phthaloyl nucleoside phosphoramidites for oligonucleotide synthesis 2002 ·Bioorganic & Medicinal Chemistry Letters ·Alexander Karpeisky, David Sweedler, Peter Haeberli, (unknown), (unknown), Leonid Beigelman	14
6	SYNTHESIS OF MODIFIED NUCLEOSIDE 5′-TRIPHOSPHATES FORIN VITROSELECTION OF CATALYTIC NUCLEIC ACIDS [1] 2001 ·Nucleosides Nucleotides & Nucleic Acids ·Jasenka Matulić‐Adamić, Andrew T. Daniher, Alexander Karpeisky, Peter Haeberli, David Sweedler, Leonid Beigelman	2
7	[3] Base-modified phosphoramidite analogs of pyrimidine ribonucleosides for RNA structure-activity studies 2000 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Leonid Beigelman, Jasenka Matulić‐Adamić, Alexander Karpeisky, Peter Haeberli, David Sweedler	4
8	Functionalized nucleoside 5′-triphosphates for in vitro selection of new catalytic ribonucleic acids 2000 ·Bioorganic & Medicinal Chemistry Letters ·Jasenka Matulić‐Adamić, Andrew T. Daniher, Alexander Karpeisky, Peter Haeberli, David Sweedler, Leonid Beigelman	33
9	The Structural Basis of Hammerhead Ribozyme Self-Cleavage 1998 ·Cell ·James B. Murray, (unknown), Lara Maloney, Alexander Karpeisky, Nassim Usman, Leonid Beigelman, W. G. Scott	153
10	Ribozyme Catalysis from the Major Groove of Group II Intron Domain 5 1998 ·Molecular Cell ·Boyana Konforti, Dana L Abramovitz, Carlos M. Duarte, Alexander Karpeisky, Leonid Beigelman, Anna Marie Pyle	63
11	Specific Recognition of an rU2-N15-rU Motif by VP55, the Vaccinia Virus Poly(A) Polymerase Catalytic Subunit 1997 ·Journal of Biological Chemistry ·Li Deng, Leonid Beigelman, Jasenka Matulić‐Adamić, Alexander Karpeisky, Paul D. Gershon	17
12	Functional groups on the cleavage site pyrimidine nucleotide are required for stabilization of the hammerhead transition state. 1997 ·PubMed ·Narayan Baidya, (unknown), (unknown), Alexander Karpeisky, Leonid Beigelman, Olke C. Uhlenbeck	13
13	Optimizing the Cell Efficacy of Synthetic Ribozymes 1996 ·Journal of Biological Chemistry ·Thale C. Jarvis, Francine E. Wincott, L. J. Alby, James A. McSwiggen, Leonid Beigelman, (unknown), Anthony B. DiRenzo, (unknown), (unknown), Jasenka Matulić‐Adamić, Alexander Karpeisky, Carolyn Gonzalez, Tod M. Woolf, Nassim Usman, Dan T. Stinchcomb	63
14	Chemically Modified Hammerhead Ribozymes with Improved Catalytic Rates 1996 ·Biochemistry ·Alex B. Burgin, Carolyn Gonzalez, Jasenka Matulić‐Adamić, Alexander Karpeisky, Nassim Usman, James A. McSwiggen, Leonid Beigelman	56
15	Synthesis of 6-Aza- & 6-Methyl-pyrimidine Ribonucleoside Phosphoramidites and Their Incorporation in Hammerhead Ribozymes 1995 ·Nucleosides and Nucleotides ·Leonid Beigelman, Alexander Karpeisky, Nassim Usman	10
16	Alternate Approaches to the Synthesis of 2′- O -Me Nucleosides 1995 ·Nucleosides and Nucleotides ·Leonid Beigelman, Alexander Karpeisky, Jasenka Matulić‐Adamić, Nassim Usman	4
17	Chemical Modification of Hammerhead Ribozymes 1995 ·Journal of Biological Chemistry ·Leonid Beigelman, James A. McSwiggen, Kenneth Draper, Carolyn Gonzalez, Kristi Jensen, Alexander Karpeisky, Anil Modak, Jasenka Matulić‐Adamić, Anthony B. DiRenzo, Peter Haeberli, David Sweedler, (unknown), Susan Grimm, Francine E. Wincott, Varykina G. Thackray, Nassim Usman	192
18	New Structural Motifs for Hammerhead Ribozymes. Catalytic Activity of Abasic Nucleotide Substituted Ribozymes 1995 ·Nucleosides Nucleotides & Nucleic Acids ·Leonid Beigelman, Alexander Karpeisky, Jasenka Matulić‐Adamić, Carolyn Gonzalez, Nassim Usman	17
19	Synthesis of 2′–modified nucleotides and their incorporation into hammerhead ribozymes 1995 ·Nucleic Acids Research ·(unknown), Alexander Karpeisky, Jasenka Matulić‐Adamić, Peter Haeberli, David Sweedler, Nassim Usman	44
20	Kinetics for the acid-catalysed hydrolysis of O-, S- and N-bridged 5′,8-cyclonucleosides related to adenosine 1994 ·Journal of the Chemical Society Perkin Transactions 2 ·Alexander Karpeisky, (unknown), Matti Hotokka, Mikko Oivanen, Harri Lönnberg	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact